HPV-related oropharyngeal cancer: a review on burden of the disease and opportunities for prevention and early detection

Mary Roz Timbang, Michael W. Sim, Arnaud F. Bewley, D. Gregory Farwell, Avinash Mantravadi, Michael G. Moore

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

The incidence of oropharyngeal cancer (OPC) related to infection with human papillomavirus (HPV) is rising, making it now the most common HPV-related malignancy in the United States. These tumors present differently than traditional mucosal head and neck cancers, and those affected often lack classic risk factors such as tobacco and alcohol use. Currently, there are no approved approaches for prevention and early detection of disease, thus leading many patients to present with advanced cancers requiring intense surgical or nonsurgical therapies resulting in significant side effects and cost to the health-care system. In this review, we outline the evolving epidemiology of HPV-related OPC. We also summarize the available evidence corresponding to HPV-related OPC prevention, including efficacy and safety of the HPV vaccine in preventing oral HPV infections. Finally, we describe emerging techniques for identifying and screening those who may be at high risk for developing these tumors.

Original languageEnglish (US)
Pages (from-to)1920-1928
Number of pages9
JournalHuman Vaccines and Immunotherapeutics
Volume15
Issue number7-8
DOIs
StatePublished - Aug 3 2019

Fingerprint

Oropharyngeal Neoplasms
Neoplasms
Papillomavirus Vaccines
Papillomavirus Infections
Tobacco Use
Head and Neck Neoplasms
Early Diagnosis
Epidemiology
Alcohols
Delivery of Health Care
Safety
Costs and Cost Analysis
Incidence
Infection

Keywords

  • detection
  • HPV
  • Oropharyngeal cancer
  • prevention
  • screening
  • vaccination

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Pharmacology

Cite this

HPV-related oropharyngeal cancer : a review on burden of the disease and opportunities for prevention and early detection. / Timbang, Mary Roz; Sim, Michael W.; Bewley, Arnaud F.; Farwell, D. Gregory; Mantravadi, Avinash; Moore, Michael G.

In: Human Vaccines and Immunotherapeutics, Vol. 15, No. 7-8, 03.08.2019, p. 1920-1928.

Research output: Contribution to journalReview article

@article{de138af7a38546eaaccea00895abddc9,
title = "HPV-related oropharyngeal cancer: a review on burden of the disease and opportunities for prevention and early detection",
abstract = "The incidence of oropharyngeal cancer (OPC) related to infection with human papillomavirus (HPV) is rising, making it now the most common HPV-related malignancy in the United States. These tumors present differently than traditional mucosal head and neck cancers, and those affected often lack classic risk factors such as tobacco and alcohol use. Currently, there are no approved approaches for prevention and early detection of disease, thus leading many patients to present with advanced cancers requiring intense surgical or nonsurgical therapies resulting in significant side effects and cost to the health-care system. In this review, we outline the evolving epidemiology of HPV-related OPC. We also summarize the available evidence corresponding to HPV-related OPC prevention, including efficacy and safety of the HPV vaccine in preventing oral HPV infections. Finally, we describe emerging techniques for identifying and screening those who may be at high risk for developing these tumors.",
keywords = "detection, HPV, Oropharyngeal cancer, prevention, screening, vaccination",
author = "Timbang, {Mary Roz} and Sim, {Michael W.} and Bewley, {Arnaud F.} and Farwell, {D. Gregory} and Avinash Mantravadi and Moore, {Michael G.}",
year = "2019",
month = "8",
day = "3",
doi = "10.1080/21645515.2019.1600985",
language = "English (US)",
volume = "15",
pages = "1920--1928",
journal = "Human Vaccines and Immunotherapeutics",
issn = "2164-5515",
publisher = "Landes Bioscience",
number = "7-8",

}

TY - JOUR

T1 - HPV-related oropharyngeal cancer

T2 - a review on burden of the disease and opportunities for prevention and early detection

AU - Timbang, Mary Roz

AU - Sim, Michael W.

AU - Bewley, Arnaud F.

AU - Farwell, D. Gregory

AU - Mantravadi, Avinash

AU - Moore, Michael G.

PY - 2019/8/3

Y1 - 2019/8/3

N2 - The incidence of oropharyngeal cancer (OPC) related to infection with human papillomavirus (HPV) is rising, making it now the most common HPV-related malignancy in the United States. These tumors present differently than traditional mucosal head and neck cancers, and those affected often lack classic risk factors such as tobacco and alcohol use. Currently, there are no approved approaches for prevention and early detection of disease, thus leading many patients to present with advanced cancers requiring intense surgical or nonsurgical therapies resulting in significant side effects and cost to the health-care system. In this review, we outline the evolving epidemiology of HPV-related OPC. We also summarize the available evidence corresponding to HPV-related OPC prevention, including efficacy and safety of the HPV vaccine in preventing oral HPV infections. Finally, we describe emerging techniques for identifying and screening those who may be at high risk for developing these tumors.

AB - The incidence of oropharyngeal cancer (OPC) related to infection with human papillomavirus (HPV) is rising, making it now the most common HPV-related malignancy in the United States. These tumors present differently than traditional mucosal head and neck cancers, and those affected often lack classic risk factors such as tobacco and alcohol use. Currently, there are no approved approaches for prevention and early detection of disease, thus leading many patients to present with advanced cancers requiring intense surgical or nonsurgical therapies resulting in significant side effects and cost to the health-care system. In this review, we outline the evolving epidemiology of HPV-related OPC. We also summarize the available evidence corresponding to HPV-related OPC prevention, including efficacy and safety of the HPV vaccine in preventing oral HPV infections. Finally, we describe emerging techniques for identifying and screening those who may be at high risk for developing these tumors.

KW - detection

KW - HPV

KW - Oropharyngeal cancer

KW - prevention

KW - screening

KW - vaccination

UR - http://www.scopus.com/inward/record.url?scp=85070094243&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85070094243&partnerID=8YFLogxK

U2 - 10.1080/21645515.2019.1600985

DO - 10.1080/21645515.2019.1600985

M3 - Review article

C2 - 31050595

AN - SCOPUS:85070094243

VL - 15

SP - 1920

EP - 1928

JO - Human Vaccines and Immunotherapeutics

JF - Human Vaccines and Immunotherapeutics

SN - 2164-5515

IS - 7-8

ER -